Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Temsirolimus

EU orphan designation number: EU/3/06/365   
Active ingredient: Temsirolimus
Indication: Treatment of renal cell carcinoma
Sponsor: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Torisel on 19/11/2007 with the number EU/1/07/424

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/04/2006 Centralised Orphan - Designation EMEA/OD/103/05 (2006)1574 of 06/04/2006
29/09/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/103/05/T/01 (2011)7048 of 27/09/2011